<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="4538">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 08, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04475185</url>
  </required_header>
  <id_info>
    <org_study_id>RC20_0173</org_study_id>
    <nct_id>NCT04475185</nct_id>
  </id_info>
  <brief_title>Safety and Effectiveness Assessment of the MakAir Artificial Ventilator</brief_title>
  <acronym>COVRESP</acronym>
  <official_title>Interventional, Open, Non-comparative, Multicenter Study to Assess the Safety and Effectiveness of the Use of the MakAir Artificial Ventilator in the Expected Situation of a Shortage of Technical Devices for Invasive Mechanical Ventilation, Linked to the Coronavirus COVID-19</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nantes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nantes University Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of our study is to carry out an evaluation of the safety and the effectiveness&#xD;
      of the use of the MakAir respirator as useful supplement in situation of shortage of&#xD;
      technical devices of assistance to the mechanical invasive ventilation, related to COVID-19&#xD;
      through a protocol in 3 successive sequences.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 20, 2020</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of dysfunctions</measure>
    <time_frame>24 hours for sequence 1</time_frame>
    <description>Number of dysfunctions which can lead to or have led to &quot;respiratory&quot; adverse events or to serious adverse events (SAE)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of dysfunctions</measure>
    <time_frame>5 days for sequence 2</time_frame>
    <description>Number of dysfunctions which can lead to or have led to &quot;respiratory&quot; adverse events or to serious adverse events (SAE)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of dysfunctions</measure>
    <time_frame>10 days for sequence 3</time_frame>
    <description>Number of dysfunctions which can lead to or have led to &quot;respiratory&quot; adverse events or to serious adverse events (SAE)</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">117</enrollment>
  <condition>Acute Respiratory Distress Syndrome</condition>
  <arm_group>
    <arm_group_label>MakAir</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MakAir</intervention_name>
    <description>MakAir artificial ventilator</description>
    <arm_group_label>MakAir</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Sequence 1 :&#xD;
&#xD;
          -  Patient for whom a certificate has been signed by a support person / family member /&#xD;
             close relative independent of the sponsor.&#xD;
&#xD;
          -  Adult&#xD;
&#xD;
          -  Non-hypoxemic patient (PaO2 / FiO2&gt; 300)&#xD;
&#xD;
          -  Patient requiring invasive mechanical ventilation&gt; 24 hours&#xD;
&#xD;
          -  Stabilized patient, i.e. not needing an increase in oxygenation for at least 6 hours&#xD;
&#xD;
        Sequence 2 :&#xD;
&#xD;
          -  Patient for whom a certificate of consent has been signed by a support person / family&#xD;
             member / close relative independent of the sponsor.&#xD;
&#xD;
          -  Adult&#xD;
&#xD;
          -  Patient with mild to moderate Acute respiratory distress syndrome (300&gt; Pa02 / FiO2&gt;&#xD;
             100)&#xD;
&#xD;
          -  Patient requiring invasive mechanical ventilation&gt; 3 days&#xD;
&#xD;
          -  Stabilized patient, i.e. having not required an increase in oxygenation for at least 6&#xD;
             hours&#xD;
&#xD;
        Sequence3 :&#xD;
&#xD;
          -  Patient for whom a certificate of consent has been signed by a support person / family&#xD;
             member / close relative independent of the sponsor or waiver due to life-threatening&#xD;
             emergency.&#xD;
&#xD;
          -  Adult&#xD;
&#xD;
          -  Patient with mild to moderate Acute respiratory distress syndrome (PaO2 / FiO2&gt; 100)&#xD;
             or without Acute respiratory distress syndrome&#xD;
&#xD;
          -  Patient requiring invasive mechanical ventilation for any duration&#xD;
&#xD;
          -  Situation of shortage among centers investigating technical devices for invasive&#xD;
             ventilation to treat all patients&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Sequence 1 and sequence 2:&#xD;
&#xD;
          -  Patient positive or showing signs of Covid-19 infection&#xD;
&#xD;
          -  Tracheotomized patient&#xD;
&#xD;
          -  History of pulmonary emphysema or severe to moderate chronic obstructive pulmonary&#xD;
             disease&#xD;
&#xD;
          -  Patient in recovery and withdrawal phase of ventilatory assistance&#xD;
&#xD;
          -  Pneumothorax or pneumomediastinum&#xD;
&#xD;
          -  Hemodynamic instability&#xD;
&#xD;
          -  Intracranial hypertension&#xD;
&#xD;
          -  Pregnant woman (A urine or blood pregnancy test must be performed for women of&#xD;
             childbearing age)&#xD;
&#xD;
          -  Major protected (guardianship, curatorship and under the protection of justice)&#xD;
&#xD;
          -  Lack of affiliation to the French social security system&#xD;
&#xD;
          -  Participation in another interventional clinical trial&#xD;
&#xD;
        Sequence3 :&#xD;
&#xD;
          -  Tracheotomized patient&#xD;
&#xD;
          -  History of pulmonary emphysema or severe to moderate moderate chronic obstructive&#xD;
             pulmonary disease&#xD;
&#xD;
          -  Patient in recovery and withdrawal phase of ventilatory assistance&#xD;
&#xD;
          -  Pneumothorax or pneumomediastinum&#xD;
&#xD;
          -  Hemodynamic instability&#xD;
&#xD;
          -  Intracranial hypertension&#xD;
&#xD;
          -  Pregnant woman (A urine or blood pregnancy test must be performed for women of&#xD;
             childbearing age)&#xD;
&#xD;
          -  Major protected (guardianship, curatorship and under the protection of justice)&#xD;
&#xD;
          -  Lack of affiliation to the French social security system&#xD;
&#xD;
          -  Participation in another interventional clinical trial on mechanical ventilation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Antoine Roquilly, MD</last_name>
    <role>Study Director</role>
    <affiliation>CHU Nantes</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Antoine Roquilly, MD</last_name>
    <phone>253482230</phone>
    <phone_ext>+33</phone_ext>
    <email>Antoine.ROQUILLY@chu-nantes.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHRU Brest</name>
      <address>
        <city>Brest</city>
        <state>Finist√®re</state>
        <zip>29200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erwan L'Her, MD</last_name>
      <email>erwan.lher@chu-brest.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Nantes</name>
      <address>
        <city>Nantes</city>
        <state>Loire-Atlantique</state>
        <zip>44000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antoine Roquilly, MD</last_name>
      <phone>(+33)253482230</phone>
      <email>antoine.roquilly@chu-nantes.fr</email>
    </contact>
    <investigator>
      <last_name>Raphael CINOTTI, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mickael VOURC'H, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>July 15, 2020</study_first_submitted>
  <study_first_submitted_qc>July 16, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 17, 2020</study_first_posted>
  <last_update_submitted>November 25, 2020</last_update_submitted>
  <last_update_submitted_qc>November 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
    <mesh_term>Acute Lung Injury</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

